ANGO

AngioDynamics, Inc.

$12.07

-0.41%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium.

Source: Yahoo Finance
AI summary

Price & performance

1M-26.2%
3M-15.7%
YTD-10.2%
1Y-1.3%
52-week range—
Beta1.09
Full chart and returns against a benchmark

Q-Score

60/ 100

Quality against peers; 50 is the peer median.

Growth48
Risk63
Performance63
Valuation58
Profitability55
Leverage60
Sentiment80
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$320.2M+9.5%
Net income-$36.7M
Net margin-11.5%+0.1 pts
Historical fundamentals

Revenue exposure

14%of revenue from outside the US
United States86%
Non-US14%
Regions, segments, customers and suppliers

Valuation

ANGOIndustryP/E—49.36P/S1.563.73EV/EBITDA—23.12P/B3.103.92PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Jan 6next report, before the open
EPS estimate$-0.07
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate